Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-25,775
Closed -$595K 3425
2025
Q2
$595K Buy
+25,775
New +$516K ﹤0.01% 1521
2025
Q1
Sell
-24,260
Closed -$457K 3129
2024
Q4
$457K Buy
24,260
+868
+4% +$19K ﹤0.01% 1500
2024
Q3
$546K Sell
23,392
-6,032
-21% -$143K ﹤0.01% 1549
2024
Q2
$683K Buy
+29,424
New +$687K ﹤0.01% 1163
2023
Q4
Sell
-43,576
Closed -$1.05M 2851
2023
Q3
$1.05M Sell
43,576
-47,184
-52% -$1.22M 0.01% 938
2023
Q2
$2.51M Buy
90,760
+63,636
+235% +$1.56M 0.02% 515
2023
Q1
$705K Buy
+27,124
New +$814K 0.01% 1154
2021
Q4
Sell
-24,896
Closed -$613K 3790
2021
Q3
$613K Buy
+24,896
New +$613K ﹤0.01% 1802

Other funds holding NVEE

HRT Financial's NVEE Position: Q3 2025 in Review

HRT Financial sold out of NV5 Global (NVEE) in Q3 2025, closing a stake of 25,775 shares — an estimated $595K sold.

HRT Financial first reported a position in NVEE in Q3 2021 and held it in 8 quarters. The position peaked at $2.51M in Q2 2023. 3 funds tracked by Wall St. Rank hold NVEE as of Q3 2025.

  • HRT Financial reported no remaining NV5 Global position as of Q3 2025 after selling out during the quarter.
  • HRT Financial sold 25,775 NV5 Global shares in Q3 2025, an estimated $595K.
  • HRT Financial first reported a position in NV5 Global in Q3 2021 and held it in 8 quarters.
  • HRT Financial's NV5 Global position peaked at $2.51M in Q2 2023.
  • 3 funds tracked by Wall St. Rank held NV5 Global as of Q3 2025.

Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.